Literature DB >> 12669274

KLOTHO allele status and the risk of early-onset occult coronary artery disease.

Dan E Arking1, Diane M Becker, Lisa R Yanek, Daniele Fallin, Daniel P Judge, Taryn F Moy, Lewis C Becker, Harry C Dietz.   

Abstract

We previously identified a functional variant of KLOTHO (termed "KL-VS"), which harbors two amino acid substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homozygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional studies to assess the association between the KL-VS allele and occult coronary artery disease (CAD) in two independent samples of apparently healthy siblings of individuals with early-onset (age <60 years) CAD (SIBS-I [N=520] and SIBS-II [N=436]). Occult CAD was defined as the occurrence of a reversible perfusion defect during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I, n=97; SIBS-II, n=56). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 (95% confidence interval 1.21-2.98) for occult CAD, after adjusting for familial intraclass correlations (P<.005). Logistic regression modeling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor (P<.019) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. Hypertension (P<.022) and increasing high-density lipoprotein cholesterol (HDL-C) levels (P<.022) mask or reduce the risk conferred by the KL-VS allele, respectively, whereas current smoking (P<.004) increases the risk. Remarkably concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS-II. These results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence the risk imposed by this allele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669274      PMCID: PMC1180268          DOI: 10.1086/375035

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome.

Authors:  Y Saito; T Nakamura; Y Ohyama; T Suzuki; A Iida; T Shiraki-Iida; M Kuro-o; Y Nabeshima; M Kurabayashi; R Nagai
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

2.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.

Authors:  I S Yuhanna; Y Zhu; B E Cox; L D Hahner; S Osborne-Lawrence; P Lu; Y L Marcel; R G Anderson; M E Mendelsohn; H H Hobbs; P W Shaul
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

3.  Validation of self-reported smoking status by simultaneous measurement of carbon monoxide and salivary thiocyanate.

Authors:  A Morabia; M S Bernstein; F Curtin; M Berode
Journal:  Prev Med       Date:  2001-01       Impact factor: 4.018

4.  Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.

Authors:  L M Hines; M J Stampfer; J Ma; J M Gaziano; P M Ridker; S E Hankinson; F Sacks; E B Rimm; D J Hunter
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

5.  Association of human aging with a functional variant of klotho.

Authors:  Dan E Arking; Alice Krebsova; Milan Macek; Milan Macek; Albert Arking; I Saira Mian; Linda Fried; Ada Hamosh; Srabani Dey; Iain McIntosh; Harry C Dietz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

6.  Improvement of multiple pathophysiological phenotypes of klotho (kl/kl) mice by adenovirus-mediated expression of the klotho gene.

Authors:  T Shiraki-Iida; A Iida; Y Nabeshima; H Anazawa; S Nishikawa; M Noda; M Kuro-o; Y Nabeshima
Journal:  J Gene Med       Date:  2000 Jul-Aug       Impact factor: 4.565

7.  Smoking in urban African Americans: behaviors, gender differences, and motivation to quit.

Authors:  M N Woods; K J Harris; J S Ahluwalia; K H Schmelzle; M S Mayo
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

Review 8.  Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.

Authors:  H R Brunner
Journal:  Am J Cardiol       Date:  2001-04-19       Impact factor: 2.778

9.  In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage.

Authors:  Haruo Mitani; Nobukazu Ishizaka; Toru Aizawa; Minoru Ohno; Shin-ichi Usui; Toru Suzuki; Toshihiro Amaki; Ichiro Mori; Yasushi Nakamura; Misako Sato; Masaomi Nangaku; Yasunobu Hirata; Ryozo Nagai
Journal:  Hypertension       Date:  2002-04       Impact factor: 10.190

10.  Nicotine metabolism variability and nicotine addiction.

Authors:  K Ahijevych
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

View more
  81 in total

1.  Promoter methylation confers kidney-specific expression of the Klotho gene.

Authors:  Masahiro Azuma; Daisuke Koyama; Jiro Kikuchi; Hiromichi Yoshizawa; Dissayabutra Thasinas; Kazuhiro Shiizaki; Makoto Kuro-o; Yusuke Furukawa; Eiji Kusano
Journal:  FASEB J       Date:  2012-07-10       Impact factor: 5.191

Review 2.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 3.  Arginase and vascular aging.

Authors:  Lakshmi Santhanam; David W Christianson; Daniel Nyhan; Dan E Berkowitz
Journal:  J Appl Physiol (1985)       Date:  2008-08-21

Review 4.  Polymorphism of klotho G-395A and susceptibility of coronary artery disease in East-Asia population: a meta-analysis.

Authors:  Changlin Zhai; Guanmin Tang; Gang Qian; Huilin Hu; Aiming Gu; Ying Fang; Xiaohong Hu; Zhiyong Wang; Shijun Wang; Ming Yao; Jiayin Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 5.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

6.  Plasma klotho and cardiovascular disease in adults.

Authors:  Richard D Semba; Anne R Cappola; Kai Sun; Stefania Bandinelli; Mansi Dalal; Candace Crasto; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2011-08-24       Impact factor: 5.562

Review 7.  Implications of Klotho in vascular health and disease.

Authors:  Ernesto Martín-Núñez; Javier Donate-Correa; Mercedes Muros-de-Fuentes; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  World J Cardiol       Date:  2014-12-26

Review 8.  Klotho and aging.

Authors:  Makoto Kuro-o
Journal:  Biochim Biophys Acta       Date:  2009-02-20

9.  Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Authors:  Tracey B Tucker Zhou; Gwendalyn D King; CiDi Chen; Carmela R Abraham
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

10.  Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells.

Authors:  Guoshun Shu; Biao Xie; Feng Ren; Dong-cai Liu; Jiapeng Zhou; Qinglong Li; Jinhui Chen; Lianwen Yuan; Jianping Zhou
Journal:  Cell Oncol (Dordr)       Date:  2012-12-18       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.